316 related articles for article (PubMed ID: 21419447)
1. Upper urinary tract carcinoma in Lynch syndrome cases.
Crockett DG; Wagner DG; Holmäng S; Johansson SL; Lynch HT
J Urol; 2011 May; 185(5):1627-30. PubMed ID: 21419447
[TBL] [Abstract][Full Text] [Related]
2. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
3. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
[TBL] [Abstract][Full Text] [Related]
4. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Mongiat-Artus P
Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
[No Abstract] [Full Text] [Related]
6. [Risk factors for urothelial carcinoma: drinking measures, smoking and other life style-related risk factors--results of the Berlin Urothelial Study (BUS)].
Helmert U; Bronder E; Klimpel A; Molzahn M; Pommer W
Gesundheitswesen; 2000 May; 62(5):270-4. PubMed ID: 10893874
[TBL] [Abstract][Full Text] [Related]
7. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
[TBL] [Abstract][Full Text] [Related]
8. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Burger M
Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
[No Abstract] [Full Text] [Related]
9. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
[TBL] [Abstract][Full Text] [Related]
10. [Increased risk of cancer in the urinary tract in patients with hereditary colorectal cancer].
Zachhau P; Walter S
Ugeskr Laeger; 2011 Oct; 173(43):2727-8. PubMed ID: 22027233
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis.
Rouprêt M; Drouin SJ; Cancel-Tassin G; Comperat E; Larré S; Cussenot O
J Urol; 2012 Feb; 187(2):424-8. PubMed ID: 22177160
[TBL] [Abstract][Full Text] [Related]
12. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
13. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
Wright JL; Hotaling J; Porter MP
J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
[TBL] [Abstract][Full Text] [Related]
14. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
Kates M; Badalato GM; Gupta M; McKiernan JM
BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
[TBL] [Abstract][Full Text] [Related]
15. Urinary tract cancer in patients with hereditary non-polyposis colorectal cancer.
Zachhau P; Walter S
Scand J Urol Nephrol; 2012 Feb; 46(1):5-7. PubMed ID: 21767247
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Malats N; Real FX
Eur Urol; 2009 Mar; 55(3):658. PubMed ID: 18584942
[No Abstract] [Full Text] [Related]
17. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Burger M
Eur Urol; 2009 Mar; 55(3):657. PubMed ID: 18584941
[No Abstract] [Full Text] [Related]
18. Uroepithelial and kidney carcinoma in Lynch syndrome.
Aarnio M; Säily M; Juhola M; Gylling A; Peltomäki P; Järvinen HJ; Mecklin JP
Fam Cancer; 2012 Sep; 11(3):395-401. PubMed ID: 22476430
[TBL] [Abstract][Full Text] [Related]
19. FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
van Oers JM; Zwarthoff EC; Rehman I; Azzouzi AR; Cussenot O; Meuth M; Hamdy FC; Catto JW
Eur Urol; 2009 Mar; 55(3):650-7. PubMed ID: 18584939
[TBL] [Abstract][Full Text] [Related]
20. Molecular subtype classification of urothelial carcinoma in Lynch syndrome.
Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F
Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
